Registration - In-house Corporation

Sequence Bio / Christopher Gardner, CEO

Registration Information

In-house Corporation name: Sequence Bio
Responsible Officer Name: Christopher Gardner, CEO
Responsible Officer Change History
Initial registration start date: 2016-08-14
Registration status: Inactive
Registration Number: 929445-358632

Associated Communications

Total Number of Communication Reports: 23

Monthly communication reports in the last 6 months: 0

Version 25 of 36 (2021-08-16 to 2021-09-15)

Registration versions:

Version 25 of 36 (2021-08-16 to 2021-09-15)

Lobbying Information

Subject Matters

Economic Development
Health
Industry
Infrastructure
Science and Technology

Subject Matter Details

Grant, Contribution or Other Financial Benefit, Policies or Program

Develop a multi-department private - public partnership with Canadian genome sequencing facilities and centres

Communication Techniques

Written communication
Oral communication
Grass-roots communication

Government Institutions

Atlantic Canada Opportunities Agency (ACOA)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
National Research Council (NRC)
Office of the Privacy Commissioner of Canada (OPC)

In-house Corporation Details

Description of activities

Biotechnology, data, life sciences and genomic research

Responsible officer name and position during the period of this registration

Christopher Gardner, CEO

Government funding

End date of the last completed financial year: 2020-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Atlantic Canada Opportunities Agency (ACOA)	$150,511.78	Yes
National Research Council (NRC)	$1,181,972.79	Yes

In-house Corporation Contact Information

Address:
53 Bond Street, Suite 100
St. John's, NL A1C 1S9
Canada

Telephone number: 800-296-3481

Parent Company Information

Sequence Bio is not a subsidiary of any other parent companies.

Subsidiary Beneficiary Information

Sequence Bio does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Christopher Gardner, CEO | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Sequence Bio/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Sequence Bio/	2016-08-14	2022-08-15

Sequence Bio

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Christopher Gardner	2016-11-28	2022-08-15
Tyler Wish	2016-08-14	2016-11-28

Christopher Gardner, CEO (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-23 of 23

Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Seamus O'Regan, Minister | House of Commons
Subject Matter of the communication: Health, Science and Technology, Economic Development
Communication date: 2020-02-06
Posted date: 2020-02-20
Communication number: 358632-463464 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Nick Whalen, Member of Parliament | House of Commons
- Seamus O'Regan, Minister | Indigenous Services | House of Commons
Subject Matter of the communication: Science and Technology
Communication date: 2019-07-23
Posted date: 2019-08-02
Communication number: 358632-458115 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sheryl Groeneweg, Director General | Office of the Deputy Minister, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
- Mark Schaan, Director General | Marketplace, Framework, Policy | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Science and Technology, Industry, Economic Development
Communication date: 2018-06-13
Posted date: 2018-07-16
Communication number: 358632-430517 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Seamus O'Regan, Minister of Veterans Affairs and Associate Minister of National Defense | Minister's Office | Veterans Affairs Canada (VAC)
- Nick Whalen, Member of Parliament | House of Commons | House of Commons
Subject Matter of the communication: Health, Science and Technology, Economic Development
Communication date: 2018-05-10
Posted date: 2018-06-15
Communication number: 358632-429162 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Iain stewart, President, NRC | Executive Offices | National Research Council (NRC)
Subject Matter of the communication: Health, Infrastructure, Science and Technology, Industry
Communication date: 2018-02-15
Posted date: 2018-03-15
Communication number: 358632-422270 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Nick Whelan, Member of the House of Commons | House of Commons
Subject Matter of the communication: Health, Science and Technology, Economic Development, Immigration
Communication date: 2018-02-09
Posted date: 2018-03-15
Communication number: 358632-422265 (amended from 358632-420029) View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- julia hiscock, Economic Research Analyst | SIPS-Atlantic | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Science and Technology, Industry
Communication date: 2018-01-05
Posted date: 2018-02-13
Communication number: 358632-419334 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2017-12-18
Posted date: 2017-12-20
Communication number: 358632-417244 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Scott Simms, Member of Parliament | Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2017-03-08
Posted date: 2017-04-15
Communication number: 358632-395503 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yvonne Jones, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2017-03-08
Posted date: 2017-04-15
Communication number: 358632-395501 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ken McDonald, Member of Parliament | House of Commons | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2017-03-08
Posted date: 2017-04-15
Communication number: 358632-395500 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gudie Hutchings, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2017-03-08
Posted date: 2017-04-15
Communication number: 358632-395499 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Seamus O'Regan, MP | House of Commons
Subject Matter of the communication: Infrastructure, Science and Technology
Communication date: 2017-02-25
Posted date: 2017-03-15
Communication number: 358632-394921 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Oliphant, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2017-02-07
Posted date: 2017-02-25
Communication number: 358632-394923 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Oliphant, MP | House of Commonss | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2017-01-29
Posted date: 2017-02-15
Communication number: 358632-394512 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- James Cowan, Senator | Senate of Canada | Senate of Canada
Subject Matter of the communication: Health, Science and Technology
Communication date: 2017-01-19
Posted date: 2017-02-15
Communication number: 358632-394507 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Senator James Cowan, Senator | Senate of Canada | Senate of Canada
Subject Matter of the communication: Health, Science and Technology
Communication date: 2016-12-16
Posted date: 2017-01-16
Communication number: 358632-392885 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- James Cowan, Senator | Senate of Canada
Subject Matter of the communication: Health, Science and Technology
Communication date: 2016-12-13
Posted date: 2017-01-16
Communication number: 358632-392886 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- James Cowan, Senator | Senate of Canada
Subject Matter of the communication: Health, Science and Technology
Communication date: 2016-10-17
Posted date: 2016-11-15
Communication number: 358632-388607 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jessica Prince, Senior Policy Advisor | Justice Canada (JC)
- Gregoire Webber, Legal Affairs Advisor | Justice Canada (JC)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2016-09-29
Posted date: 2016-11-04
Communication number: 358632-385613 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Matheson, Director of Policy | House of Commons
Subject Matter of the communication: Infrastructure, Science and Technology
Communication date: 2016-09-28
Posted date: 2016-11-04
Communication number: 358632-385616 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Judy Foote, Minister | Procurement | Public Services and Procurement Canada (PSPC)
- Gianluca Cairo, Chief of Staff | Public Services and Procurement Canada (PSPC)
Subject Matter of the communication: Health, Infrastructure, Science and Technology
Communication date: 2016-09-27
Posted date: 2016-11-04
Communication number: 358632-385609 View associated registration
Sequence Bio
In-house Corporation

Designated Public Office Holders who participated in the communication:
- James Cowan, Senator | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2016-09-13
Posted date: 2016-11-04
Communication number: 358632-385607 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Sequence Bio / Christopher Gardner, CEO

Registration Information

Associated Communications

Version 25 of 36 (2021-08-16 to 2021-09-15)

Version 25 of 36 (2021-08-16 to 2021-09-15)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit, Policies or Program

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties